SCHEMBL8416508

SCHEMBL8416508

OC(OCCN1CCCCC1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.61
SLC6A3 Q01959 3/20 0.61
CYP3A4 P08684 2/20 0.61
DRD1 P21728 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2D6 P10635 1/20 0.61
TSHR P16473 1/20 0.61
CYP2C19 P33261 1/20 0.61
HIF1A Q16665 1/20 0.61
SLC22A1 O15245 1/20 0.61
CHRM2 P08172 1/20 0.61
HTR1A P08908 1/20 0.61
ADRA2A P08913 1/20 0.61
CHRM1 P11229 1/20 0.61
TBXA2R P21731 1/20 0.61
SLC6A2 P23975 1/20 0.61
ADRA1A P35348 1/20 0.61
OPRM1 P35372 1/20 0.61
DRD3 P35462 1/20 0.61
KCNH2 Q12809 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Perastine SCHEMBL1506306 0.83 CYP3A4 (0.83) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
Perastine SCHEMBL29768269 0.82 CYP3A4 (0.83) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
SCHEMBL5708552 0.82 TSHR (0.67) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
SCHEMBL7332031 0.80 SLC6A4 (0.57) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
SCHEMBL11398777 0.77 SLC6A4 (0.55) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
Cloperastine SCHEMBL284715 0.76 SLC6A2 (1.00) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
SCHEMBL17942915 0.76 CYP3A4 (0.75) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
Cloperastine SCHEMBL9613613 0.76 SLC6A2 (1.00) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
Cloperastine SCHEMBL29617329 0.76 SLC6A2 (1.00) SLC6A4SLC6A3CYP3A4DRD1CYP1A2
SCHEMBL14033921 0.76 LTA4H (0.97) DRD1LTA4HDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5856341-A INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS INCLUDING HYPERLIPIDEMIA, ESTROGEN-DEPENDENT CANCER ELI LILLY AND COMPANY (US) 1999-01-05 US disclosed